We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FEATURED ARTICLES

 

Latest Articles

Should Infectious Diseases Be Made Notifiable? The Good, the Bad and the Ugly
Article

At first glance this question might seem like a no-brainer. Surely if you make an infectious disease notifiable then you are better able to contain infection and prevent it spreading, right? Unfortunately, whilst the principle seems simple, the reality is far less so. Here we take a look at the different facets and implications of making an infectious disease notifiable.

READ MORE

Meet "Mr Christmas Tree", the Scientist Who Researches Christmas Trees All Year Round
Article

Wouldn't it be grand if it could be Christmas every day? Well, for one researcher, it sort of is. Meet Plant Pathologist and Extension Specialist Professor Gary Chastagner, also commonly referred to as "Mr Christmas Tree", a scientist who researches Christmas trees 365 days a year.

READ MORE

Biosecurity – From the Horse’s Mouth
Article

"Biosecurity” encompasses a wide range of important topics, from bioterrorism to invasive alien species of both plants and animals. But for the purposes of this article, we are going to focus on the prevention of outbreaks of disease and how to minimize the spread when they do inevitably happen.

READ MORE

Who Will Win the "Race to the Bottom" in the Infectious Disease Testing Market?
Article

When it comes to testing for infectious diseases, it seems some companies are engaged in a “race to the bottom” to provide the cheapest test possible. Ever-lower price points might be attractive for cash-strapped governments, NGOs and charities engaged in the ongoing fight against infectious diseases, but are such practices putting us at risk of compromising quality?

READ MORE

Advances in PCR Diagnostics for Cancer and Medical Mycology
Article

From detecting cancer to microbial infections, and now even fungal infections, PCR has become the gold standard of analyzing gene expression. In this article, we explore how PCR is used as a novel diagnostic strategy to identify clinically important yeast species, as well as to detect mutations that could guide therapeutic decisions for lung cancer patients.

READ MORE

Advances in Cancer Drug Discovery
Article

From optimizing immunotherapy to second-guessing cancer’s next evolutionary step – there has never been a more innovative era in cancer drug discovery.

READ MORE

New Compound Targets the Link Between Poor Diet, Inflammation and Alzheimer's Disease
Article

Could therapies targeting our immune system help treat Alzheimer's disease by flipping long-standing research theories on their head? A new drug targeting a two-faced protein is currently undergoing clinical trials to find an answer.

READ MORE

Key Themes and Conversations From the First Lab of the Future Congress
Article

What do we mean by lab of the future? What innovations are required to get there? These are the key themes explored by this year's Lab of the Future Congress, summarized in this article.

READ MORE

Technology Networks Explores the CRISPR Revolution: An Interview With Professor Glenn Cohen, World-leading Expert on Bioethics
Article

In this feature of Technology Networks Explores the CRISPR Revolution, we interview Professor Glenn Cohen, director of Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics.

READ MORE

The Value and Versatility of Clinical Flow Cytometry
Article

Flow cytometry has inarguable potential as a clinical tool for disease diagnosis, prognosis, and therapeutic monitoring. However, some challenges remain in translating the full promise of FCM into clinical practice. Here, some of the current clinical applications of FCM will be discussed, as well as some of the compelling new applications being researched.

READ MORE

 
Advertisement